Full history for every metric is available with a Kvantra account
Enfusion, Inc. (ENFN)
Key financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 59 | 80 | 112 | 150 | 175 | 202 | 202 |
| Operating profit | $m | 6 | 6 | |||||
| Net profit | $m | 13 | 4 | -282 | -13 | 6 | 3 | 3 |
| EPS reported | $ | 0.01 | 0.02 | |||||
| Operating cashflow per share | $ | 0.38 | 0.38 | |||||
| Capex per share | $ | 0.04 | 0.04 | |||||
| FCF per share | $ | 0.34 | 0.34 | |||||
| Free cash flow | $m | 31 | 24 | |||||
| Net debt | $m | -34 | -54 | |||||
| Book value equity | $m | 73 | 73 | |||||
| Book value per share | $ | 0.57 | 0.57 | |||||
| Number of shares | m | 129.55 | 129.56 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 768.66 | - | |||||
| P/B LTM | x | 12.95 | 13.93 | |||||
| P/S LTM | x | 4.70 | 5.06 | |||||
| P/FCF LTM | x | 30.54 | 42.88 | |||||
| EV/EBITDA LTM | x | 148.48 | 65.86 | |||||
| EV/Sales LTM | x | 4.53 | 4.79 | |||||
| Earnings Yield LTM | % | 0.13% | 0.29% | |||||
| FCF Yield | % | 3.27% | 2.33% | |||||
| Quality | ||||||||
| ROE | % | 3.86% | 4.45% | |||||
| ROIC | % | 1.93% | 1.93% | |||||
| Operating margin | % | 3.05% | 3.05% | |||||
| Gross margin | % | 67.82% | 67.82% | |||||
| FCF/Sales | % | 15.40% | 15.40% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -81.26% | -81.26% | |||||
| Sales Growth YoY | % | +15.51% | +15.51% | |||||
| Net Income Growth YoY | % | -53.15% | -53.15% | |||||
| FCF Growth | % | +94.49% | +94.49% | |||||
| Operating Profit Growth | % | -48.49% | -48.49% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 1.53 | 1.17 | |||||
| Net Debt/EBITDA | x | -5.55 | -5.55 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -3.60% | -5.34% | |||||
| Net debt/Equity | x | -0.47 | -0.74 | |||||
| Gross debt/equity | x | 0.28 | 0.28 | |||||
Company overview
Enfusion, Inc. supplies cloud-based software solutions designed for the investment management sector, operating throughout the United States, Europe, the Middle East, Africa, and the Asia Pacific. Its product suite includes a sophisticated portfolio management system, which establishes an instant and comprehensive investment record. This system incorporates valuation and risk assessment tools, allowing chief investment officers (CIOs) and portfolio managers to analyze aggregated or granular portfolio data. The company also offers an order and execution management system, enabling portfolio managers, traders, compliance teams, and analysts to electronically transmit and manage trade orders across various asset classes. This system simultaneously enforces trading regulations and internal operational guidelines. Additionally, Enfusion provides an accounting and general ledger system that serves as a real-time financial book of record, vital for chief financial officers (CFOs), chief operating officers (COOs), accountants, and operations teams. Furthermore, the Enfusion analytics system empowers CIOs, portfolio managers, traders, and analysts to scrutinize portfolios over different timeframes and automatically generate customized visual reports for both internal and external stakeholders. Complementing these software offerings, Enfusion also delivers technology-powered and managed services. Enfusion Inc. was founded in 2021 and is headquartered in Chicago, Illinois.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Enfusion, Inc. (ENFN)
Enfusion, Inc. supplies cloud-based software solutions designed for the investment management sector, operating throughout the United States, Europe, the Middle East, Africa, and the Asia Pacific. Its product suite includes a sophisticated portfolio management system, which establishes an instant and comprehensive investment record. This system incorporates valuation and risk assessment tools, allowing chief investment officers (CIOs) and portfolio managers to analyze aggregated or granular portfolio data. The company also offers an order and execution management system, enabling portfolio managers, traders, compliance teams, and analysts to electronically transmit and manage trade orders across various asset classes. This system simultaneously enforces trading regulations and internal operational guidelines. Additionally, Enfusion provides an accounting and general ledger system that serves as a real-time financial book of record, vital for chief financial officers (CFOs), chief operating officers (COOs), accountants, and operations teams. Furthermore, the Enfusion analytics system empowers CIOs, portfolio managers, traders, and analysts to scrutinize portfolios over different timeframes and automatically generate customized visual reports for both internal and external stakeholders. Complementing these software offerings, Enfusion also delivers technology-powered and managed services. Enfusion Inc. was founded in 2021 and is headquartered in Chicago, Illinois.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free